Teva Pharmaceuticals stocks soar following Mylan takeover speculations

April 18, 2015 4:05 PM

52 0

Generic drugmaker Mylan NV moved quickly on Friday to pour cold water on published reports that Teva Pharmaceuticals Industries is considering a bid to acquire it.

Mylan last week announced a $29 billion offer to buy Perrigo Co Plc in a move that some analysts suggested was a tactic to help fend off an acquisition by larger rival Teva. Mylan Executive Chairman and former Chief Executive Officer Robert Coury said the Perrigo plans remain on track.

Also read: Dow gains 100 points amid deluge of corporate news; real estate leads

Read more

To category page